GSK plc reports

Company location
London
GSK plc has filed 6,769 SEC EDGAR filings since 12 Jan 2001

SEC filing history

Showing 1-25 of 1,000 matching filings.

Per page
25
Current page
1
6-K File 001-15170

DIRECTOR/PDMR SHAREHOLDING

Filing date
11 Jun 2026
Reporting date
11 Jun 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
SC TO-C

SC TO-C

Filing date
10 Jun 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-15170

DIRECTOR/PDMR SHAREHOLDING

Filing date
10 Jun 2026
Reporting date
10 Jun 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
SC TO-C

SC TO-C

Filing date
09 Jun 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-15170

DR HAL BARRON - NEW DIRECTORSHIP

Filing date
09 Jun 2026
Reporting date
09 Jun 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
SC TO-C

SC TO-C

Filing date
09 Jun 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-15170

GSK ENTERS AGREEMENT TO ACQUIRE NUVALENT, INC.

Filing date
09 Jun 2026
Reporting date
09 Jun 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-15170

TRANSACTION IN OWN SHARES

Filing date
08 Jun 2026
Reporting date
08 Jun 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-15170

TOTAL VOTING RIGHTS

Filing date
01 Jun 2026
Reporting date
01 Jun 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-15170

TRANSACTION IN OWN SHARES

Filing date
01 Jun 2026
Reporting date
01 Jun 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-15170

POSITIVE PHASE 3 DATA FOR BEPIROVIRSEN

Filing date
28 May 2026
Reporting date
28 May 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-15170

DIRECTOR/PDMR SHAREHOLDING

Filing date
27 May 2026
Reporting date
27 May 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
SD File 001-15170

SPECIALIZED DISCLOSURE REPORT

Filing date
26 May 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-15170

ADMISSION TO TRADING

Filing date
26 May 2026
Reporting date
26 May 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-15170

TRANSACTION IN OWN SHARES

Filing date
26 May 2026
Reporting date
26 May 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-15170

Q2 2026 RESULTS DATE CONFIRMED - 28 JULY 2026

Filing date
22 May 2026
Reporting date
22 May 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-15170

DIRECTOR/PDMR SHAREHOLDING

Filing date
20 May 2026
Reporting date
20 May 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-15170

DIRECTOR/PDMR SHAREHOLDING

Filing date
20 May 2026
Reporting date
20 May 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-15170

DIRECTOR/PDMR SHAREHOLDING

Filing date
19 May 2026
Reporting date
19 May 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-15170

TRANSACTION IN OWN SHARES

Filing date
18 May 2026
Reporting date
18 May 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-15170

JAPAN MHLW APPROVES AREXVY FOR ADULTS 18-49 AIR

Filing date
18 May 2026
Reporting date
18 May 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
13F-HR File 028-26280

13F-HR filing

Filing date
14 May 2026
Reporting date
31 Mar 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-15170

DIRECTOR/PDMR SHAREHOLDING

Filing date
14 May 2026
Reporting date
14 May 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-15170

DIRECTOR/PDMR SHAREHOLDING

Filing date
11 May 2026
Reporting date
11 May 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-15170

COLLABORATION WITH CTTQ FOR BEPIROVIRSEN

Filing date
11 May 2026
Reporting date
11 May 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .